Retatrutide 40mg/3ml NAD SM SMO OV TB TR RT 99% White powder weight loss china factory high quality price advantage
TDS 18 Inquiries
62568-57-4
Pharmaceutical Grade
99%
HONG KONG
Peptide
10mg/10 bottles per box
2026-09-11
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Product Description
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionECHEMI Editorial Referenceδ-Sleep Inducing Peptide is a neuropeptide, with antioxidant and anxiolytic properties.Certificates
-
TDS
Basic Info-
Product Name:
Dsip
CAS No.:62568-57-4
Molecular Formula:C35H48N10O15
InChIKeys:ZRZROXNBKJAOKB-GFVHOAGBSA-N
Molecular Weight:848.8
Exact Mass:848.33006086
UNII:YN28Z5YZ73
Categories:
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Location:
Room 11B, Building 0056, No. 81-1 Nonglinxia Road, Yuexiu District, Guangzhou City, Guangdong Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History18 Inquiries
Country Product Purchase Quantity Date Posted
United States
dsip
100 G May 17, 2026
United States
DSIP
10 MT Apr 27, 2026
United States
DSIP
10 Apr 13, 2026
United States
DSIP
1 MT Apr 10, 2026
United States
Dsip
100 MT Feb 3, 2026
United States
Dsip
1 MT Dec 17, 2025
Italy
Adipotide
100 MG Jun 2, 2024
United States
DSIP
100 MG Nov 28, 2025
United Kingdom
Dsip
10 MG Jun 17, 2026
United States
Dsip
10 G Jan 12, 2026
Germany
Dsip
1 MT Apr 26, 2026
United States
DSIP
10 MT Mar 12, 2026
United States
DSIP
10 MG Jan 12, 2026
United States
DSIP
1 G Nov 10, 2025
United States
dsip
1 Oct 20, 2025
United States
DSIP lyphilized powder
100 MG Jun 24, 2025
United States
Adipotide 5mg 10vial kit
1 MT Feb 25, 2024
United States
Epitalon, NAD+, DSIP, 5-Amino-1MQ, PEG-MGF
1 May 9, 2026 Post an enquiry for this product